Recurrent and functional regulatory mutations in breast cancer
Esther Rheinbay1,2, Prasanna Parasuraman2, Jonna Grimsby1
1The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02124, USA.
Nature
|June 29, 2017
Summary
Cancer-causing mutations frequently occur in promoter regions, not just coding genes. This study identified key promoter mutations in breast cancer, impacting gene expression and revealing new avenues for cancer research.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Genomic analysis has primarily focused on coding regions for cancer gene identification.
- Non-coding regions, particularly promoters, are understudied for their role in cancer development.
Purpose of the Study:
- To identify significantly mutated promoter regions in breast cancer using deep sequencing.
- To investigate the functional consequences of these promoter mutations on gene expression.
Main Methods:
- Deep sequencing of 360 primary breast cancer samples.
- Development of computational methods to detect significantly mutated promoters.
- Analysis of mutation impact on transcription factor binding and gene expression.
Main Results:
- Identified recurrent mutations in the promoters of three genes: FOXA1, RMRP, and NEAT1.
- FOXA1 promoter mutations lead to overexpression via increased E2F binding in hormone-receptor positive breast cancer.
- Mutations in RMRP and NEAT1 promoters alter protein binding and gene expression levels.
Conclusions:
- Promoter regions harbor recurrent, functionally significant mutations in cancer at frequencies comparable to coding regions.
- These findings highlight the importance of non-coding regions in cancer genomics.
- Further deep sequencing of large patient cohorts is needed to discover additional cancer-associated promoter mutations.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K


